Example: Heart Attack

Search clinical trials for: Exenatide

Total 341 results

NCT03456687

Active, not recruiting

Effects of Exenatide on Motor Function and the Brain

Conditions: Parkinson's Disease
NCT02533453

Completed

A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.

Conditions: Type 2 Diabetes Mellitus
NCT03002675

Unknown status

Exenatide and Brown Adipose Tissue

Conditions: Obesity
NCT03645408

Suspended

The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers

Conditions: Alcohol Use Disorder
NCT01444898

Completed

Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome

Conditions: Prader-Willi Syndrome
NCT02847403

Recruiting

Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients

Conditions: Dysglycemia; Cognitive Deficit
NCT04303819

Completed

The Effect of Exenatide on Fasting Bile Acids

Conditions: Type 2 Diabetes Mellitus in Obese
NCT00623545

Completed

Bioenergetic Alterations After Exenatide Administration

Conditions: Healthy
NCT01061775

Completed

Effects of Exenatide on Hypothalamic Obesity

Conditions: Hypothalamic Obesity
NCT03160261

Completed

Effect of Exenatide on Cortisol Secretion

Conditions: Healthy
NCT02735031

Completed

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Conditions: Diabetes Mellitus, Type 1; Hypoglycemia
NCT01056549

Completed

Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans

Conditions: Hyperlipidemia
NCT02380521

Completed

Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes

Conditions: Type 2 Diabetes Mellitus
NCT00736229

Completed

Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients

Conditions: Hyperglycemia; Acute Coronary Syndromes; Myocardial Infarction
NCT00529204

Terminated

Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease

Conditions: Diabetes Complications; Fatty Liver
NCT03287076

Recruiting

Trial of EXenatide in Acute Ischaemic Stroke

Conditions: Acute Ischemic Stroke
NCT01652716

Completed

Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes

Conditions: Diabetes Mellitus, Type 2
NCT01971242

Completed

Trial of Exenatide for Parkinson's Disease

Conditions: Parkinson's Disease
NCT00845559

Withdrawn

The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults

Conditions: Obesity; Insulin Resistance; Impaired Glucose Tolerance; Cardiovascular Disease
NCT04001231

Withdrawn

Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes
NCT01006889

Completed

Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Conditions: Nonalcoholic Fatty Liver Disease; Type 2 Diabetes Mellitus
NCT01938235

Unknown status

Exenatide for Myocardial Protection During Reperfusion Study

Conditions: Myocardial Infarction
NCT01484873

Completed

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

Conditions: Obesity; Overweight; Craniopharyngioma
NCT02160990

Completed

Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying

Conditions: Obesity
NCT01580514

Completed

Myocardial Protection of Exenatide in AMI

Conditions: Myocardial Infarction